Literature DB >> 11483404

Involuntary movements in infantile cobalamin deficiency appearing after treatment.

E A Ozer1, M Turker, A R Bakiler, I Yaprak, C Ozturk.   

Abstract

Involuntary movements may be a symptom in most infants who present with neurologic syndrome of infantile cobalamin (vitamin B12) deficiency. In this report, two infants with cobalamin deficiency are presented. These patients also developed a striking movement disorder that appeared a few days after treatment with intramuscular cobalamin. The movement disorder was characterized by severe involuntary movements, which were a combination of tremor and myoclonus particularly involving tongue, face, pharynx, and legs. The neurologic symptoms improved within a few days after the administration of clonazepam. In each patient the mother was also cobalamin deficient and the infant was solely breast-fed. The cause of involuntary movements that can appear rarely after treatment in infantile cobalamin deficiency is not known. Besides initial neurologic presenting symptoms of cobalamin deficiency, the occurrence of involuntary movements after treatment should also receive attention. This movement disorder may disappear spontaneously, or an additional treatment may be an alternative approach if the symptoms are severe.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11483404     DOI: 10.1016/s0887-8994(01)00289-2

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  7 in total

Review 1.  Cobalamin status in children.

Authors:  Anne-Lise Bjørke-Monsen; Per Magne Ueland
Journal:  J Inherit Metab Dis       Date:  2010-05-27       Impact factor: 4.982

Review 2.  Recreational Nitrous Oxide Abuse: Prevalence, Neurotoxicity, and Treatment.

Authors:  Yuanyuan Xiang; Lei Li; Xiaotong Ma; Shan Li; Yuan Xue; Peng Yan; Meijie Chen; Junwei Wu
Journal:  Neurotox Res       Date:  2021-03-26       Impact factor: 3.911

3.  Post-Treatment Movement Disorder in a Child with Late-onset Cobalamin Deficiency.

Authors:  Ala Fadilah; Peter S Baxter; Ptolemaios G Sarrigiannis; Soma Sengupta; Mark J Sharrard; Santosh R Mordekar
Journal:  Mov Disord Clin Pract       Date:  2021-12-27

Review 4.  Drug-induced myoclonus: frequency, mechanisms and management.

Authors:  Félix Javier Jiménez-Jiménez; Inmaculada Puertas; María de Toledo-Heras
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

5.  Growth retardation, general hypotonia, and loss of acquired neuromotor skills in the infants of mothers with cobalamin deficiency and the possible role of succinyl-CoA and glycine in the pathogenesis.

Authors:  Zafer Bicakci
Journal:  Medicine (Baltimore)       Date:  2015-03       Impact factor: 1.889

6.  Infantile tremor syndrome: Role of Vitamin B12 revisited.

Authors:  Rajesh Gupta; Jagdish Mandliya; Pavan Sonker; Vandana Patil; Manish Agrawal; Ashish Pathak
Journal:  J Pediatr Neurosci       Date:  2016 Oct-Dec

Review 7.  The clinical heterogeneity of drug-induced myoclonus: an illustrated review.

Authors:  Sabine Janssen; Bastiaan R Bloem; Bart P van de Warrenburg
Journal:  J Neurol       Date:  2016-12-16       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.